| P50 | author | Stephen A Whelan | Q58326849 |
| | Wagner B Dias | Q58326856 |
| P2093 | author name string | Isadora A Oliveira | |
| | Adriane Regina Todeschini | |
| | Andréia Vasconcelos-Dos-Santos | |
| | Miguel Clodomiro Lucena | |
| | Natalia Rodrigues Mantuano | |
| P2860 | cites work | Cloning of a novel member of the UDP-galactose:beta-N-acetylglucosamine beta1,4-galactosyltransferase family, beta4Gal-T4, involved in glycosphingolipid biosynthesis | Q22004161 |
| | A beta-1,3-N-acetylglucosaminyltransferase with poly-N-acetyllactosamine synthase activity is structurally related to beta-1,3-galactosyltransferases | Q22008686 |
| | Cloning and expression of a proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I. A seventh member of the human beta4-galactosyltransferase gene family | Q22010511 |
| | Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2,6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens | Q22010719 |
| | Identification and characterization of three novel beta 1,3-N-acetylglucosaminyltransferases structurally related to the beta 1,3-galactosyltransferase family | Q24290427 |
| | Phosphofructokinase 1 glycosylation regulates cell growth and metabolism | Q24297510 |
| | Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling | Q24313363 |
| | A family of human beta4-galactosyltransferases. Cloning and expression of two novel UDP-galactose:beta-n-acetylglucosamine beta1, 4-galactosyltransferases, beta4Gal-T2 and beta4Gal-T3 | Q24314565 |
| | Expression cloning of cDNA encoding a human beta-1,3-N-acetylglucosaminyltransferase that is essential for poly-N-acetyllactosamine synthesis | Q24314988 |
| | The expanding beta 4-galactosyltransferase gene family: messages from the databanks | Q24318549 |
| | Expression of the developmental I antigen by a cloned human cDNA encoding a member of a beta-1,6-N-acetylglucosaminyltransferase gene family | Q24322660 |
| | A novel beta1,3-N-acetylglucosaminyltransferase (beta3Gn-T8), which synthesizes poly-N-acetyllactosamine, is dramatically upregulated in colon cancer | Q24336874 |
| | Structure of human O-GlcNAc transferase and its complex with a peptide substrate | Q24337218 |
| | Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3T3-L1 adipocytes | Q24648559 |
| | Molecular cloning of a human cDNA encoding beta-1,4-galactosyltransferase with 37% identity to mammalian UDP-Gal:GlcNAc beta-1,4-galactosyltransferase | Q24672069 |
| | Haploinsufficiency of C2GnT-I glycosyltransferase renders T lymphoma cells resistant to cell death | Q24685820 |
| | N-glycans in cell survival and death: cross-talk between glycosyltransferases | Q27027708 |
| | Crystal structures of the bovine beta 4galactosyltransferase catalytic domain and its complex with uridine diphosphogalactose | Q27618915 |
| | Crystal structure of beta1,4-galactosyltransferase complex with UDP-Gal reveals an oligosaccharide acceptor binding site | Q27639089 |
| | Structural insights into mechanism and specificity of O-GlcNAc transferase | Q27652304 |
| | O-GlcNAc transferase invokes nucleotide sugar pyrophosphate participation in catalysis | Q27674743 |
| | A neutral diphosphate mimic crosslinks the active site of human O-GlcNAc transferase | Q27675565 |
| | Specificity of Processing -Glucosidase I Is Guided by the Substrate Conformation: CRYSTALLOGRAPHIC AND IN SILICO STUDIES | Q27677099 |
| | Bisubstrate UDP–peptide conjugates as human O-GlcNAc transferase inhibitors | Q27680651 |
| | On the Origin of Cancer Cells | Q27861025 |
| | Prognostic significance of UDP‐N‐acetyl‐α‐D‐galactosamine:polypeptide N‐acetylgalactosaminyltransferase‐3 (GalNAc‐T3) expression in patients with gastric carcinoma | Q28199057 |
| | Expression of uridine diphosphate N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase 3 in adenocarcinoma of the pancreas | Q28209189 |
| | Mucins in cancer: protection and control of the cell surface | Q28235006 |
| | Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression | Q28254372 |
| | Glycolysis inhibition for anticancer treatment | Q28256222 |
| | Purification of two glycoproteins expressing beta 1-6 branched Asn-linked oligosaccharides from metastatic tumour cells | Q28275660 |
| | Siglecs and their roles in the immune system | Q28294469 |
| | Molecular cloning and expression of a novel beta-1, 6-N-acetylglucosaminyltransferase that forms core 2, core 4, and I branches | Q28294981 |
| | Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins | Q28299550 |
| | Five specificity patterns of (1----3)-alpha-L-fucosyltransferase activity defined by use of synthetic oligosaccharide acceptors. Differential expression of the enzymes during human embryonic development and in adult tissues | Q28316034 |
| | A bisubstrate analog inhibitor for alpha(1----2)-fucosyltransferase | Q28342980 |
| | Differential expression of the Lewis Y antigen defined by monoclonal antibody C14/1/46/10 in colonic polyps | Q69636906 |
| | Suppressed expression of blood group B antigen and blood group galactosyltransferase in a preleukemic subject | Q69963428 |
| | Effect of inhibitors of glycosylation and carbohydrate processing on invasion of malignant mouse MO4 cells in organ culture | Q69976955 |
| | Glycoprotein modifications of sarcoma L-1 tumor cells by tunicamycin, swainsonine, bromoconduritol or 1-desoxynojirimycin treatment inhibits their metastatic lung colonization in Balb/c-mice | Q70049884 |
| | Blood group-related antigens in human germ cell tumors | Q70200256 |
| | Activity of the human blood group ABO, Se, H, Le, and X gene-encoded glycosyltransferases in normal and malignant bladder urothelium | Q70394893 |
| | Castanospermine, a tetrahydroxylated alkaloid that inhibits beta-glucosidase and beta-glucocerebrosidase | Q70429718 |
| | Inhibition of N-linked oligosaccharide processing in tumor cells is associated with enhanced tissue inhibitor of metalloproteinases (TIMP) gene expression | Q70568015 |
| | Expression of alpha-1,3-fucosyltransferase type IV and VII genes is related to poor prognosis in lung cancer | Q70840050 |
| | Involvement of N-acetyl-lactosamine-containing sugar structures in the liver metastasis of mouse colon carcinoma (colon 26) cells | Q71675210 |
| | Benzyl-N-acetyl-alpha-D-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation | Q71762333 |
| | Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium | Q72067065 |
| | Expression of Sialyl Lewisa as a new prognostic factor for patients with advanced colorectal carcinoma | Q72112395 |
| | Up-regulation of the oligosaccharide sialyl LewisX: a new prognostic parameter in metastatic prostate cancer | Q72187133 |
| | Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study | Q72226978 |
| | Progress in pharmacology of cerebral ischemia | Q72483455 |
| | Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase | Q72750319 |
| | Induction of suppressor T cells by neuraminic acid derivatives | Q72771528 |
| | A search for pyrophosphate mimics for the development of substrates and inhibitors of glycosyltransferases | Q73354887 |
| | Synthesis and biological evaluation of new UDP-GalNAc analogues for the study of polypeptide-alpha-GalNAc-transferases | Q73400279 |
| | Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma | Q73507939 |
| | Characterization of the N-oligosaccharides attached to the atypical Asn-X-Cys sequence of recombinant human epidermal growth factor receptor | Q73580767 |
| | Thomsen-Friedenreich antigen presents as a prognostic factor in colorectal carcinoma: A clinicopathologic study of 264 patients | Q73595096 |
| | Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas | Q73963471 |
| | The C-disaccharide alpha-C(1-->3)-mannopyranoside of N-acetylgalactosamine is an inhibitor of glycohydrolases and of human alpha-1,3-fucosyltransferase VI. Its epimer alpha-(1-->3)-mannopyranoside of N-acetyltalosamine is not | Q73983003 |
| | Synthesis of the First Tricomponent Bisubstrate Analogue That Exhibits Potent Inhibition against GlcNAc:beta-1,4-Galactosyltransferase | Q74835614 |
| | Overexpression of alpha1-6 fucosyltransferase in hepatoma cells suppresses intrahepatic metastasis after splenic injection in athymic mice | Q77415654 |
| | Acceptor substrate-based selective inhibition of galactosyltransferases | Q77749861 |
| | Panosialins, inhibitors of an alpha1,3-fucosyltransferase Fuc-TVII, suppress the expression of selectin ligands on U937 cells | Q77937139 |
| | UDP-Gal: GlcNAc-R beta1,4-galactosyltransferase--a target enzyme for drug design. Acceptor specificity and inhibition of the enzyme | Q79151523 |
| | Non-isosteric C-glycosyl analogues of natural nucleotide diphosphate sugars as glycosyltransferase inhibitors | Q79914266 |
| | Stachybotrydial, a potent inhibitor of fucosyltransferase and sialyltransferase | Q81729837 |
| | Different levels of sialyl-Tn antigen expressed on MUC16 in patients with endometriosis and ovarian cancer | Q83517332 |
| | N-glycan biosynthesis inhibitors induce in vitro anticancer activity in colorectal cancer cells | Q84061409 |
| | Identification and assessment of new biomarkers for colorectal cancer with serum N-glycan profiling | Q84792401 |
| | Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer | Q85888507 |
| | Immunohistochemical expression of core 2 β1,6-N-acetylglucosaminyl transferase 1 (C2GnT1) in endometrioid-type endometrial carcinoma: a novel potential prognostic factor | Q86655191 |
| | Inhibition of sialyltransferases of murine lymphocytes by disaccharide nucleosides | Q93594207 |
| | Molecular cloning of brain-specific GD1alpha synthase (ST6GalNAc V) containing CAG/Glutamine repeats | Q28508776 |
| | Cell surface and Golgi pools of beta-1,4-galactosyltransferase are differentially regulated during embryonal carcinoma cell differentiation | Q28511313 |
| | Purification, cDNA cloning, and expression of UDP-Gal: glucosylceramide beta-1,4-galactosyltransferase from rat brain | Q28581590 |
| | The biology of cancer: metabolic reprogramming fuels cell growth and proliferation | Q29547301 |
| | Plasma membrane domain organization regulates EGFR signaling in tumor cells | Q30480578 |
| | Regulation of calcium/calmodulin-dependent kinase IV by O-GlcNAc modification. | Q30490721 |
| | Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells | Q30540051 |
| | Human fucosyltransferase 6 enables prostate cancer metastasis to bone | Q30559315 |
| | The cancer glycocalyx mechanically primes integrin-mediated growth and survival | Q30656235 |
| | Selective inhibition of beta-1,4- and alpha-1,3-galactosyltransferases: donor sugar-nucleotide based approach | Q30675849 |
| | Synthesis of novel donor mimetics of UDP-Gal, UDP-GlcNAc, and UDP-GalNAc as potential transferase inhibitors | Q30870958 |
| | Small molecule inhibitors of mucin-type O-linked glycosylation from a uridine-based library | Q31056671 |
| | Cell surface-specific N-glycan profiling in breast cancer | Q31137153 |
| | The relative activities of the C2GnT1 and ST3Gal-I glycosyltransferases determine O-glycan structure and expression of a tumor-associated epitope on MUC1. | Q31705505 |
| | Molecular cloning and functional expression of a fifth-type alpha 2,3-sialyltransferase (mST3Gal V: GM3 synthase). | Q31942000 |
| | Purification and characterization of UDP-GlcNAc:Galbeta1-4GlcNAcbeta1-3*Galbeta1-4Glc(NAc)-R(GlcNAc to *Gal) beta1,6N-acetylglucosaminyltransferase from hog small intestine | Q32003154 |
| | Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation | Q32058522 |
| | The chicken genome contains two functional nonallelic beta1,4-galactosyltransferase genes. Chromosomal assignment to syntenic regions tracks fate of the two gene lineages in the human genome. | Q32184176 |
| | Phase I trial of the anti-Lewis Y drug immunoconjugate BR96-doxorubicin in patients with lewis Y-expressing epithelial tumors | Q33180441 |
| | Rational design, synthesis, and characterization of novel inhibitors for human beta1,4-galactosyltransferase | Q33223341 |
| | Tumor beta-1,4-galactosyltransferase IV overexpression is closely associated with colorectal cancer metastasis and poor prognosis | Q33229798 |
| | N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry | Q33548177 |
| | The endoplasmic reticulum chaperone Cosmc directly promotes in vitro folding of T-synthase | Q33593911 |
| | O-GlcNAcylation: The Sweet Side of the Cancer | Q33701447 |
| | Polypeptide N-acetylgalactosaminyltransferase 2 regulates cellular metastasis-associated behavior in gastric cancer | Q33703870 |
| | Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer | Q33783766 |
| | Oligosaccharyltransferase: a complex multisubunit enzyme of the endoplasmic reticulum | Q33797976 |
| | Trypanosoma cruzi subverts host cell sialylation and may compromise antigen-specific CD8+ T cell responses | Q33809905 |
| | Tissue distribution of histo-blood group antigens | Q33852459 |
| | Alpha1,3-fucosyltransferase 9 (FUT9; Fuc-TIX) preferentially fucosylates the distal GlcNAc residue of polylactosamine chain while the other four alpha1,3FUT members preferentially fucosylate the inner GlcNAc residue | Q33885664 |
| | alpha1,6fucosyltransferase is highly and specifically expressed in human ovarian serous adenocarcinomas | Q33926327 |
| | Neuronal expression of Mgat1 rescues the shortened life span of Drosophila Mgat11 null mutants and increases life span | Q34006812 |
| | Glycosylation defining cancer malignancy: new wine in an old bottle | Q34074081 |
| | alpha2,3-sialyltransferase ST3Gal III modulates pancreatic cancer cell motility and adhesion in vitro and enhances its metastatic potential in vivo | Q34098948 |
| | Serum N-glycan alteration associated with renal cell carcinoma detected by high throughput glycan analysis | Q35021015 |
| | The identification and characterization of novel N-glycan-based biomarkers in gastric cancer. | Q35023434 |
| | Polypeptide N-acetylgalactosaminyltransferase 6 expression in pancreatic cancer is an independent prognostic factor indicating better overall survival | Q35034722 |
| | gem-Diamine 1-N-iminosugars and related iminosugars, candidate of therapeutic agents for tumor metastasis | Q35061492 |
| | Unfolded protein response is required in nu/nu mice microvasculature for treating breast tumor with tunicamycin | Q35309992 |
| | Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process | Q35470512 |
| | Biosynthesis and Function of ß 1,6 Branched Mucin-Type Glycans | Q35554091 |
| | Tumor-Associated Carbohydrate Antigens Defining Tumor Malignancy: Basis for Development of Anti-Cancer Vaccines | Q35554103 |
| | Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells | Q35595004 |
| | Enhancement of metastatic ability by ectopic expression of ST6GalNAcI on a gastric cancer cell line in a mouse model. | Q35745593 |
| | O-GlcNAc signalling: implications for cancer cell biology | Q35793071 |
| | Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease | Q35804446 |
| | Gene expression of O-GlcNAc cycling enzymes in human breast cancers | Q35809895 |
| | Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis | Q35879559 |
| | MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7. | Q35922278 |
| | Tight complex formation between Cosmc chaperone and its specific client non-native T-synthase leads to enzyme activity and client-driven dissociation | Q35939823 |
| | O-GlcNAcylation of kinases | Q36070732 |
| | Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability | Q36233025 |
| | Galectin-3 protein regulates mobility of N-cadherin and GM1 ganglioside at cell-cell junctions of mammary carcinoma cells | Q36294909 |
| | Three-dimensional structures of carbohydrate determinants of Lewis system antigens: implications for effective antibody targeting of cancer | Q36304930 |
| | Epigenetic silencing of the chaperone Cosmc in human leukocytes expressing tn antigen | Q36436153 |
| | Glycolysis inhibitor screening identifies the bis-geranylacylphloroglucinol protonophore moronone from Moronobea coccinea. | Q36494623 |
| | Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer | Q36535243 |
| | The mTOR inhibitor AZD8055 inhibits proliferation and glycolysis in cervical cancer cells | Q36611732 |
| | Overexpression of alpha(1,3)-fucosyltransferase VII is sufficient for the acquisition of lung colonization phenotype in human lung adenocarcinoma HAL-24Luc cells | Q36618060 |
| | UDP-Gal: betaGlcNAc beta1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumour antigen recognised by HLA-A2-restricted cytotoxic T lymphocytes from patients with brain tumour | Q36624402 |
| | Suppression of FUT1 attenuates cell proliferation in the HER2-overexpressing cancer cell line NCI-N87 | Q36642333 |
| | Development of orally active inhibitors of protein and cellular fucosylation | Q36747458 |
| | The potential importance of swainsonine in therapy for cancers and immunology | Q36839125 |
| | Carbohydrate antigen sialyl Lewis a--its pathophysiological significance and induction mechanism in cancer progression | Q36924223 |
| | miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. | Q36926211 |
| | Galectin-3- and phospho-caveolin-1-dependent outside-in integrin signaling mediates the EGF motogenic response in mammary cancer cells | Q36961108 |
| | Inhibition of N-linked glycosylation disrupts receptor tyrosine kinase signaling in tumor cells | Q36967036 |
| | O-GlcNAc modification in diabetes and Alzheimer's disease | Q36973321 |
| | The Lewis-Y carbohydrate antigen is expressed by many human tumors and can serve as a target for genetically redirected T cells despite the presence of soluble antigen in serum | Q39879986 |
| | Role of E-cadherin N-glycosylation profile in a mammary tumor model | Q39892493 |
| | Enhanced expression of beta 3-galactosyltransferase 5 activity is sufficient to induce in vivo synthesis of extended type 1 chains on lactosylceramides of selected human colonic carcinoma cell lines. | Q39896654 |
| | O-linked beta-N-acetylglucosaminyltransferase substrate specificity is regulated by myosin phosphatase targeting and other interacting proteins. | Q39931631 |
| | Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc | Q40002603 |
| | Involvement of alpha 1-2-fucosyltransferase I (FUT1) and surface-expressed Lewis(y) (CD174) in first endothelial cell-cell contacts during angiogenesis | Q40023034 |
| | Inhibitors of the Biosynthesis and Processing of N-Linked Oligosaccharide | Q40116930 |
| | Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. | Q40147884 |
| | A mutant chaperone converts a wild-type protein into a tumor-specific antigen | Q40220542 |
| | Biological significance of cancer-associated sialyl-Tn antigen: modulation of malignant phenotype in gastric carcinoma cells. | Q40233254 |
| | N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha3beta1 integrin-mediated cell migration | Q40238492 |
| | beta1,4-N-Acetylglucosaminyltransferase III potentiates beta1 integrin-mediated neuritogenesis induced by serum deprivation in Neuro2a cells | Q40306035 |
| | Soyasaponin I decreases the expression of alpha2,3-linked sialic acid on the cell surface and suppresses the metastatic potential of B16F10 melanoma cells | Q40326598 |
| | Metabolic inhibition of galectin-1-binding carbohydrates accentuates antitumor immunity. | Q40401752 |
| | Pilot study of a heptavalent vaccine-keyhole limpet hemocyanin conjugate plus QS21 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer | Q40444431 |
| | Stable expression of sialyl-Tn antigen in T47-D cells induces a decrease of cell adhesion and an increase of cell migration. | Q40446171 |
| | Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cells. | Q40455268 |
| | Soyasaponin-I-modified invasive behavior of cancer by changing cell surface sialic acids. | Q40468532 |
| | Expression of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-12 in gastric and colonic cancer cell lines and in human colorectal cancer. | Q40489058 |
| | Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen | Q40507967 |
| | Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. | Q40508811 |
| | Synthesis of N-acetyllactosamine derivatives with variation in the aglycon moiety for the study of inhibition of sialyl Lewis x expression | Q40636020 |
| | Role of oligomannosidic N-glycans in the proliferation, adhesion and signalling of C6 glioblastoma cells | Q40645340 |
| | Immunization of ovarian cancer patients with a synthetic Lewis(y)-protein conjugate vaccine: a phase 1 trial | Q40872664 |
| | The level of cell surface beta1,4-galactosyltransferase I influences the invasive potential of murine melanoma cells. | Q40940802 |
| | Increase of rat colon carcinoma cells tumorigenicity by alpha(1-2) fucosyltransferase gene transfection | Q41122410 |
| | Suppression of sialyl Lewis X expression and E-selectin-mediated cell adhesion in cultured human lymphoid cells by transfection of antisense cDNA of an alpha1-->3 fucosyltransferase (Fuc-T VII). | Q41145801 |
| | Biosynthesis of O-glycans in leukocytes from normal donors and from patients with leukemia: increase in O-glycan core 2 UDP-GlcNAc:Gal beta 3 GalNAc alpha-R (GlcNAc to GalNAc) beta(1-6)-N-acetylglucosaminyltransferase in leukemic cells. | Q41178692 |
| | Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance | Q41179543 |
| | Metabolic inhibition of sialyl-Lewis X biosynthesis by 5-thiofucose remodels the cell surface and impairs selectin-mediated cell adhesion. | Q41461652 |
| | O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer | Q41464494 |
| | Functional role of N-glycosylation in alpha 5 beta 1 integrin receptor. De-N-glycosylation induces dissociation or altered association of alpha 5 and beta 1 subunits and concomitant loss of fibronectin binding activity. | Q41473286 |
| | Perspectives on the significance of altered glycosylation of glycoproteins in cancer | Q41594921 |
| | Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer. | Q41594926 |
| | Increased UDP-GlcNAc:Gal beta 1-3GaLNAc-R (GlcNAc to GaLNAc) beta-1, 6-N-acetylglucosaminyltransferase activity in metastatic murine tumor cell lines. Control of polylactosamine synthesis | Q41699139 |
| | Synthesis of glycopyranosylphosphonate analogues of certain natural nucleoside diphosphate sugars as potential inhibitors of glycosyltransferases | Q42216218 |
| | Synthesis of certain nucleoside methylenediphosphonate sugars as potential inhibitors of glycosyltransferases | Q42216220 |
| | Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome | Q42321222 |
| | Importance of E‐selectin (ELAM‐1) and sialyl lewisa in the adhesion of pancreatic carcinoma cells to acttvated endothelium | Q42483494 |
| | Lewis Y antigen as detected by the monoclonal antibody BR96 is expressed strongly in prostatic adenocarcinoma | Q42484753 |
| | Apposite insulin-like growth factor (IGF) receptor glycosylation is critical to the maintenance of vascular smooth muscle phenotype in the presence of factors promoting osteogenic differentiation and mineralization. | Q42728392 |
| | Cytochemical staining for beta 1,6 branching of asparagine-linked oligosaccharides in variants of metastatic human colon carcinoma cells | Q42753998 |
| | GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker. | Q42787448 |
| | Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia. | Q43547830 |
| | Selective inhibition of glycosyltransferases by bivalent imidazolium salts | Q43581055 |
| | Soyasaponin I, a potent and specific sialyltransferase inhibitor | Q43631707 |
| | Heterologous over-expression of alpha-1,6-fucosyltransferase from Rhizobium sp.: application to the synthesis of the trisaccharide beta-D-GlcNAc(1-->4)-[alpha-L-Fuc-(1-->6)]-D-GLcNAc, study of the acceptor specificity and evaluation of polyhydroxyla | Q43669120 |
| | Over-expression of beta-1,4-galactosyltransferase I, II, and V in human astrocytoma | Q43704811 |
| | STn and prognosis in breast cancer. | Q43807787 |
| | An inhibitor of the human UDP-GlcNAc 4-epimerase identified from a uridine-based library: a strategy to inhibit O-linked glycosylation | Q43884212 |
| | Identification of mannose 6-phosphate in two asparagine-linked sugar chains of recombinant transforming growth factor-beta 1 precursor. | Q44258575 |
| | Clinical and prognostic implications of β1, 6-N-acetylglucosaminyltransferase V in patients with gastric cancer | Q44788875 |
| | Inhibition of fucosyltransferase VII by gallic acid and its derivatives | Q44842720 |
| | Differences in prognosis of colorectal cancer patients based on the expression of sialyl Lewisa, sialyl Lewisx and sialyl Tn antigens in serum and tumor tissue. | Q45031048 |
| | Asymmetric synthesis and affinity of potent sialyltransferase inhibitors based on transition-state analogues. | Q45108458 |
| | C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization. | Q45158681 |
| | Prognostic influence of loss of blood group A antigen expression in pathologic stage I non-small-cell lung cancer. | Q45231458 |
| | Expression of histo-blood-group-A/B-gene-defined glycosyltransferases in normal and malignant epithelia: correlation with A/B-carbohydrate expression | Q45767094 |
| | MDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions. | Q45984505 |
| | Endothelial-selectin ligands sialyl Lewis(x) and sialyl Lewis(a) are differentiation antigens immunogenic in human melanoma. | Q45997022 |
| | Bidirectional N-acetylglucosamine transfer mediated by beta-1,4-N-acetylglucosaminyltransferase III. | Q46190757 |
| | Inhibition of mucin glycosylation by aryl-N-acetyl-alpha-galactosaminides in human colon cancer cells. | Q46374429 |
| | Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas. | Q37040588 |
| | Exploring the glycosylation of serum CA125. | Q37139074 |
| | N-Glycans in cancer progression | Q37243167 |
| | Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1). | Q37346082 |
| | Increasing O-GlcNAc levels: An overview of small-molecule inhibitors of O-GlcNAcase. | Q37576207 |
| | N-glycan structures: recognition and processing in the ER. | Q37620688 |
| | Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility | Q37623994 |
| | Metabolism, cell surface organization, and disease | Q37671886 |
| | Mgat1-dependent N-glycans are essential for the normal development of both vertebrate and invertebrate metazoans | Q37703536 |
| | Functional Roles of the Bisecting GlcNAc in Integrin-Mediated Cell Adhesion | Q37785143 |
| | Modulation of E-cadherin function and dysfunction by N-glycosylation. | Q37812004 |
| | The Tn antigen-structural simplicity and biological complexity | Q37831859 |
| | O-GlcNAc in cancer biology | Q38120210 |
| | Chemical tools to probe cellular O-GlcNAc signalling. | Q38155213 |
| | Complex N-glycans: the story of the "yellow brick road". | Q38157785 |
| | Expression and function of α2,3‐sialyl‐ and α,3/l,4‐fucosyltransferases in colon adenocarcinoma cell lines: Role in synthesis of E‐selectin counter‐receptors | Q38289196 |
| | Increased glycosylation of beta 1 integrins affects the interaction of transformed S115 mammary epithelial cells with laminin-1. | Q38293968 |
| | Inhibition of UDP-GlcNAc:Gal beta 1-3GalNAc-R (GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase from acute myeloid leukaemia cells by photoreactive nitrophenyl substrate derivatives | Q38311889 |
| | α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues | Q38315106 |
| | Glycosyltransferases as cell adhesion molecules | Q38315602 |
| | Glycogenes mediate the invasive properties and chemosensitivity of human hepatocarcinoma cells | Q38320455 |
| | Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells | Q38331636 |
| | Enhanced expression of alpha(1,3)-fucosyltransferase genes correlates with E-selectin-mediated adhesion and metastatic potential of human lung adenocarcinoma cells. | Q38338605 |
| | Effects of swainsonine and polyinosinic:polycytidylic acid on murine tumor cell growth and metastasis | Q38350429 |
| | Transcriptional regulation of the N-acetylglucosaminyltransferase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by Ets-1. | Q38352116 |
| | Effects of tunicamycin on B16 metastatic melanoma cell surface glycoproteins and blood-borne arrest and survival properties | Q38356075 |
| | Poly N-acetyllactosamine substitutions on N- and not O-oligosaccharides or Thomsen-Friedenreich antigen facilitate lung specific metastasis of melanoma cells via galectin-3. | Q38359737 |
| | Hijacking a biosynthetic pathway yields a glycosyltransferase inhibitor within cells. | Q38845236 |
| | 2-Deoxyglucose induces cell cycle arrest and apoptosisin colorectal cancer cells independent of its glycolysis inhibition | Q38902242 |
| | Inhibition of cancer cell growth by GRP78 siRNA lipoplex via activation of unfolded protein response | Q39008885 |
| | Tunicamycin potentiates cisplatin anticancer efficacy through the DPAGT1/Akt/ABCG2 pathway in mouse Xenograft models of human hepatocellular carcinoma | Q39077984 |
| | ER stress suppresses DNA double-strand break repair and sensitizes tumor cells to ionizing radiation by stimulating proteasomal degradation of Rad51. | Q39097758 |
| | The mucin-type glycosylating enzyme polypeptide N-acetylgalactosaminyltransferase 14 promotes the migration of ovarian cancer by modifying mucin 13. | Q39147421 |
| | A novel I-branching beta-1,6-N-acetylglucosaminyltransferase involved in human blood group I antigen expression | Q34162929 |
| | O-GlcNAc signaling: a metabolic link between diabetes and cancer? | Q34172895 |
| | Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase (ST6GalNac I) cDNA. | Q34207920 |
| | ABH and Lewis histo-blood group antigens in cancer | Q34215529 |
| | Control of glycoprotein synthesis. Bovine colostrum UDP-N-acetylglucosamine:alpha-D-mannoside beta 2-N-acetylglucosaminyltransferase I. Separation from UDP-N-acetylglucosamine:alpha-D-mannoside beta 2-N-acetylglucosaminyltransferase II, partial [...] | Q34260660 |
| | Association between expression levels of CA 19-9 and N-acetylglucosamine-beta;1,3-galactosyltransferase 5 gene in human pancreatic cancer tissue | Q34269464 |
| | Suppression of beta 1,3galactosyltransferase beta 3Gal-T5 in cancer cells reduces sialyl-Lewis a and enhances poly N-acetyllactosamines and sialyl-Lewis x on O-glycans | Q34285184 |
| | Introduction of bisecting GlcNAc into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration. | Q34302948 |
| | A unique small molecule inhibitor of enolase clarifies its role in fundamental biological processes | Q34336513 |
| | Snail1 is stabilized by O-GlcNAc modification in hyperglycaemic condition | Q34337315 |
| | Histochemical demonstration and analysis of poly-N-acetyllactosamine structures in normal and malignant human tissues | Q34389864 |
| | Fucosyltransferases: structure/function studies | Q34392726 |
| | Lewis (y) antigen overexpression increases the expression of MMP-2 and MMP-9 and invasion of human ovarian cancer cells | Q34396078 |
| | Evidences for the involvement of cell surface glycans in stem cell pluripotency and differentiation | Q34407362 |
| | Suppression of cancer progression by MGAT1 shRNA knockdown. | Q34407965 |
| | Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene | Q34433644 |
| | The sweet and sour of cancer: glycans as novel therapeutic targets | Q34439560 |
| | The ST6GalNAc-I sialyltransferase localizes throughout the Golgi and is responsible for the synthesis of the tumor-associated sialyl-Tn O-glycan in human breast cancer. | Q34471553 |
| | Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis | Q34549268 |
| | Suppression of core 1 Gal-transferase is associated with reduction of TF and reciprocal increase of Tn, sialyl-Tn and Core 3 glycans in human colon cancer cells | Q34639786 |
| | Increase of O-glycosylated oncofetal fibronectin in high glucose-induced epithelial-mesenchymal transition of cultured human epithelial cells. | Q34673248 |
| | Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions | Q34683362 |
| | O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells. | Q34747232 |
| | Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin | Q34763642 |
| | Molecular imaging of cancer with positron emission tomography | Q34810431 |
| | New castanospermine glycoside analogues inhibit breast cancer cell proliferation and induce apoptosis without affecting normal cells | Q35016962 |
| | Expression of a differentiation antigen and poly-N-acetyllactosaminyl O-glycans directed by a cloned core 2 beta-1,6-N-acetylglucosaminyltransferase. | Q46426976 |
| | Synthesis of poly-N-acetyllactosamine in core 2 branched O-glycans. The requirement of novel beta-1,4-galactosyltransferase IV and beta-1,3-n-acetylglucosaminyltransferase | Q46525727 |
| | Altered melanoma cell surface glycosylation mediates organ specific adhesion and metastasis via lectin receptors on the lung vascular endothelium | Q46678523 |
| | Complex N-glycans are the major ligands for galectin-1, -3, and -8 on Chinese hamster ovary cells | Q46828658 |
| | CD45 modulates galectin-1-induced T cell death: regulation by expression of core 2 O-glycans | Q46897587 |
| | C2GnT-M is downregulated in colorectal cancer and its re-expression causes growth inhibition of colon cancer cells. | Q46898189 |
| | Lithocholic acid analogues, new and potent alpha-2,3-sialyltransferase inhibitors. | Q46919457 |
| | Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. | Q46989470 |
| | Cell-cell interaction-dependent regulation of N-acetylglucosaminyltransferase III and the bisected N-glycans in GE11 epithelial cells. Involvement of E-cadherin-mediated cell adhesion | Q46990459 |
| | Systematic nomenclature for sialyltransferases | Q48783973 |
| | Kinetic analysis of a recombinant UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase. | Q50759829 |
| | Blood vessel invasion and expression of sialyl Lewisx and proliferating cell nuclear antigen in stage I non-small cell lung cancer. Relation to postoperative recurrence. | Q50775156 |
| | Purification and characterization of UDP-GlcNAc:Gal beta 1-4Glc(NAc) beta-1,3-N-acetylglucosaminyltransferase (poly-N-acetyllactosamine extension enzyme) from calf serum. | Q50777388 |
| | Optimised chemical synthesis of 5-substituted UDP-sugars and their evaluation as glycosyltransferase inhibitors. | Q51756028 |
| | ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues. | Q51767552 |
| | O-GlcNAc transferase: a sweet new cancer target. | Q53251909 |
| | Expression and enzyme activity of alpha(1,6)fucosyltransferase in human colorectal cancer. | Q53321104 |
| | Enzymatic basis for the structural changes of asparagine-linked sugar chains of membrane glycoproteins of baby hamster kidney cells induced by polyoma transformation. | Q53544439 |
| | Susceptibility of rat colon carcinoma cells to lymphokine activated killer-mediated cytotoxicity is decreased by alpha1,2-fucosylation. | Q54052675 |
| | Prediction of bladder cancer based on urinary content of MGEA5 and OGT mRNA level. | Q54301420 |
| | MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase. | Q54312855 |
| | UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (ppGalNAc-T6) mRNA as a potential new marker for detection of bone marrow-disseminated breast cancer cells. | Q54610237 |
| | Chemo-enzymatic synthesis of fluorinated sugar nucleotide: useful mechanistic Probes for glycosyltransferases | Q56953153 |
| | Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors | Q58058353 |
| | Association of N-Glycosylation with Breast Carcinoma and Systemic Features Using High-Resolution Quantitative UPLC | Q60531021 |
| | Novel Glycan Biomarkers for the Detection of Lung Cancer | Q60678388 |
| | Levels of specific serum N-glycans identify breast cancer patients with higher circulating tumor cell counts | Q60678398 |
| | Regulation of Rat‐Liver Glycoprotein: N‐Acetylneuraminic Acid Transferase Activity by Pyrimidine Nucleotides | Q67324054 |
| | Amphomycin inhibition of mannose and GlcNAc incorporation into lipid-linked saccharides | Q67417774 |
| | Poly-N-acetyllactosaminyl O-glycans attached to leukosialin. The presence of sialyl Le(x) structures in O-glycans | Q67945544 |
| | Synthesis of a new inhibitor of the UDP-GalNAc:polypeptide galactosaminyl transferase | Q67986571 |
| | Evaluation of deoxygenated oligosaccharide acceptor analogs as specific inhibitors of glycosyltransferases | Q68010600 |
| | Beta 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia | Q68179327 |
| | Blood group and blood-group-related antigens in normal pancreas and pancreas cancer: enhanced expression of precursor type 1, Tn and sialyl-Tn in pancreas cancer | Q68183867 |
| | Glycosylation inhibitors for N-linked glycoproteins | Q69076427 |
| | Inhibition of experimental pulmonary metastasis of mouse colon adenocarcinoma 26 sublines by a sialic acid:nucleoside conjugate having sialyltransferase inhibiting activity | Q69609449 |
| | E-cadherin and adherens-junctions stability in gastric carcinoma: functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases III and V. | Q39152300 |
| | Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours | Q39169405 |
| | A correlation between altered O-GlcNAcylation, migration and with changes in E-cadherin levels in ovarian cancer cells | Q39176619 |
| | β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma | Q39187979 |
| | ppGalNAc T1 as a potential novel marker for human bladder cancer. | Q39211086 |
| | Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity | Q39242218 |
| | Swainsonine promotes apoptosis in human oesophageal squamous cell carcinoma cells in vitro and in vivo through activation of mitochondrial pathway | Q39244938 |
| | B4GALT1 gene knockdown inhibits the hedgehog pathway and reverses multidrug resistance in the human leukemia K562/adriamycin-resistant cell line | Q39268689 |
| | Estrogen induced β-1,4-galactosyltransferase 1 expression regulates proliferation of human breast cancer MCF-7 cells | Q39278007 |
| | The TF-antigen binding lectin from Sclerotium rolfsii inhibits growth of human colon cancer cells by inducing apoptosis in vitro and suppresses tumor growth in vivo | Q39338882 |
| | MUC1 carrying core 2 O-glycans functions as a molecular shield against NK cell attack, promoting bladder tumor metastasis | Q39374390 |
| | pp-GalNAc-T13 induces high metastatic potential of murine Lewis lung cancer by generating trimeric Tn antigen. | Q39401563 |
| | Functional analysis of α1,3/4-fucosyltransferase VI in human hepatocellular carcinoma cells | Q39430940 |
| | Metabolic glycoengineering through the mammalian GalNAc salvage pathway | Q39431599 |
| | Down-regulation of FUT3 and FUT5 by shRNA alters Lewis antigens expression and reduces the adhesion capacities of gastric cancer cells | Q39462216 |
| | regulation of the invasion and metastasis of human glioma cells by polypeptide N-acetylgalactosaminyltransferase 2. | Q39482946 |
| | O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation | Q39565095 |
| | O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy | Q39604562 |
| | A novel sialyltransferase inhibitor suppresses FAK/paxillin signaling and cancer angiogenesis and metastasis pathways | Q39609194 |
| | Specificity of β1,4-galactosyltransferase inhibition by 2-naphthyl 2-butanamido-2-deoxy-1-thio-β-D-glucopyranoside | Q39639800 |
| | Synthetic Antitumor Vaccines from Tetanus Toxoid Conjugates of MUC1 Glycopeptides with the Thomsen–Friedenreich Antigen and a Fluorine‐Substituted Analogue | Q39650206 |
| | Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains | Q39664965 |
| | Angiotensin AT1 receptor activation mediates high glucose-induced epithelial-mesenchymal transition in renal proximal tubular cells. | Q39686680 |
| | Synthesis of N-, S-, and C-glycoside castanospermine analogues with selective neutral alpha-glucosidase inhibitory activity as antitumour agents. | Q39692460 |
| | Molecular imaging of N-linked glycosylation suggests glycan biosynthesis is a novel target for cancer therapy | Q39711705 |
| | Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis | Q39730101 |
| | Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1. | Q39734008 |
| | Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides | Q39735775 |
| | A novel sialyltransferase inhibitor AL10 suppresses invasion and metastasis of lung cancer cells by inhibiting integrin-mediated signaling. | Q39746392 |
| | Core 2 N-acetylglucosaminyltransferase-1 expression induces aggressive potential of testicular germ cell tumor | Q39762155 |
| | alpha1,2-Fucosylated and beta-N-acetylgalactosaminylated prostate-specific antigen as an efficient marker of prostatic cancer | Q39763616 |
| | Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells. | Q39795184 |
| | High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells | Q39796701 |
| P921 | main subject | glycosylation | Q898365 |
| P304 | page(s) | 138 | |
| P577 | publication date | 2015-06-25 | |
| P1433 | published in | Frontiers in Oncology | Q26839986 |
| P1476 | title | Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer | |
| P478 | volume | 5 | |